192 related articles for article (PubMed ID: 26906063)
21. Rituximab in the treatment of refractory lupus nephritis with vasculitis.
Kadikoy H; Haque W; Ahmed S; Abdellatif A
Saudi J Kidney Dis Transpl; 2012 Mar; 23(2):334-7. PubMed ID: 22382230
[TBL] [Abstract][Full Text] [Related]
22. Peripheral Blood B Cell Depletion after Rituximab and Complete Response in Lupus Nephritis.
Gomez Mendez LM; Cascino MD; Garg J; Katsumoto TR; Brakeman P; Dall'Era M; Looney RJ; Rovin B; Dragone L; Brunetta P
Clin J Am Soc Nephrol; 2018 Oct; 13(10):1502-1509. PubMed ID: 30089664
[TBL] [Abstract][Full Text] [Related]
23. Induction therapy with rituximab for lupus nephritis due to prolidase deficiency.
Sato S; Ohnishi T; Uejima Y; Furuichi M; Fujinaga S; Imai K; Nakamura K; Kawano Y; Suganuma E
Rheumatology (Oxford); 2020 Oct; 59(10):e57-e59. PubMed ID: 32107546
[No Abstract] [Full Text] [Related]
24. New and future therapies for lupus nephritis.
Appel GB
Cleve Clin J Med; 2012 Feb; 79(2):134-40. PubMed ID: 22301564
[TBL] [Abstract][Full Text] [Related]
25. A Case of NCAM1-Positive Lupus Nephritis with NCAM1 Antibody Titers Responsive to Rituximab.
Wang Y; Chen R; Han M; Liu S; Xie Q; Hao C
Nephron; 2024; 148(5):312-318. PubMed ID: 37778328
[TBL] [Abstract][Full Text] [Related]
26. [Rituximab therapy for severe pediatric systemic lupus erythematosus].
Su GX; Wu FQ; Wang F; Zhou ZX; Huang XL; Lu J
Zhonghua Er Ke Za Zhi; 2012 Sep; 50(9):697-704. PubMed ID: 23158822
[TBL] [Abstract][Full Text] [Related]
27. Lupus nephritis and B-cell targeting therapy.
Cassia M; Alberici F; Gallieni M; Jayne D
Expert Rev Clin Immunol; 2017 Oct; 13(10):951-962. PubMed ID: 28800401
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and safety of tacrolimus therapy for lupus nephritis: a systematic review of clinical trials.
Lee YH; Lee HS; Choi SJ; Dai Ji J; Song GG
Lupus; 2011 May; 20(6):636-40. PubMed ID: 21382917
[TBL] [Abstract][Full Text] [Related]
29. Rituximab is an effective treatment for lupus nephritis and allows a reduction in maintenance steroids.
Pepper R; Griffith M; Kirwan C; Levy J; Taube D; Pusey C; Lightstone L; Cairns T
Nephrol Dial Transplant; 2009 Dec; 24(12):3717-23. PubMed ID: 19617257
[TBL] [Abstract][Full Text] [Related]
30. Exploring new territory: the move towards individualised treatment.
Haubitz M
Lupus; 2007; 16(3):227-31. PubMed ID: 17432112
[TBL] [Abstract][Full Text] [Related]
31. Combination therapy of rituximab and mycophenolate mofetil in childhood lupus nephritis.
Hogan J; Godron A; Baudouin V; Kwon T; Harambat J; Deschênes G; Niel O
Pediatr Nephrol; 2018 Jan; 33(1):111-116. PubMed ID: 28780657
[TBL] [Abstract][Full Text] [Related]
32. Single-dose rituximab in refractory lupus nephritis.
Kotagiri P; Martin A; Hughes P; Becker G; Nicholls K
Intern Med J; 2016 Aug; 46(8):899-901. PubMed ID: 27242250
[TBL] [Abstract][Full Text] [Related]
33. Rituximab in the real-world treatment of lupus nephritis: A retrospective cohort study in Japan.
Tanaka Y; Nakayamada S; Yamaoka K; Ohmura K; Yasuda S
Mod Rheumatol; 2023 Jan; 33(1):145-153. PubMed ID: 35165714
[TBL] [Abstract][Full Text] [Related]
34. Optimum therapeutic approaches for lupus nephritis: what therapy and for whom?
Boumpas DT; Sidiropoulos P; Bertsias G
Nat Clin Pract Rheumatol; 2005 Nov; 1(1):22-30. PubMed ID: 16932624
[TBL] [Abstract][Full Text] [Related]
35. Targeting B-cells in lupus nephritis: should cautious optimism remain?
Rovin BH
Nephrol Dial Transplant; 2013 Jan; 28(1):7-9. PubMed ID: 22844105
[No Abstract] [Full Text] [Related]
36. [The LUNAR study: rituximab for lupus nephritis?].
Specker C
Z Rheumatol; 2013 Apr; 72(3):300-2. PubMed ID: 23262655
[No Abstract] [Full Text] [Related]
37. Intensive short-term treatment with rituximab, cyclophosphamide and methylprednisolone pulses induces remission in severe cases of SLE with nephritis and avoids further immunosuppressive maintenance therapy.
Roccatello D; Sciascia S; Rossi D; Alpa M; Naretto C; Baldovino S; Menegatti E; La Grotta R; Modena V
Nephrol Dial Transplant; 2011 Dec; 26(12):3987-92. PubMed ID: 21385860
[TBL] [Abstract][Full Text] [Related]
38. Risk of serious infections with immunosuppressive drugs and glucocorticoids for lupus nephritis: a systematic review and network meta-analysis.
Singh JA; Hossain A; Kotb A; Wells G
BMC Med; 2016 Sep; 14(1):137. PubMed ID: 27623861
[TBL] [Abstract][Full Text] [Related]
39. Update on the management of lupus nephritis: let the treatment fit the patient.
Bertsias G; Boumpas DT
Nat Clin Pract Rheumatol; 2008 Sep; 4(9):464-72. PubMed ID: 18756272
[TBL] [Abstract][Full Text] [Related]
40. Treatment for refractory lupus nephritis: Rituximab vs triple target therapy.
Cervera R; Mosca M; Ríos-Garcés R; Espinosa G; Trujillo H; Bada T; Praga M
Autoimmun Rev; 2019 Dec; 18(12):102406. PubMed ID: 31654743
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
